Bone and Periodontal Tissue Regeneration by the Secretomes from Bone Marrow Derived Mesenchymal Stem Cells - New Trends in Tissue Engineering and Regenerative Medicine - page 107

hema-topoietic cell homing. J Biomed Opt Vol. 11, No.5, (January 2007), pp.50507,
ISSN 1083-3668.
[11] Katagiri W, Osugi M, Kawai T & Ueda M. (2013). Novel cell-free regenerative medi‐
cine of bone using stem cell derived factors. Int J Oral Maxillofac Implants Vol. 28, No.
4, (March 2014), pp.1009-1016, ISSN 1942-4434.
[12] Kawasaki K, Aihara M, Honmo J, Sakurai S, Fujimaki Y, Sakamoto K, Fujimaki E,
Wozney JM & Yamaguchi A. (1998). Effects of reconmbinant human bone morphoge‐
netic protein-2 on differentiation of cells isolated from human bone, muscle, and
skin. Bone 1998: 23, No.3, (December 1998), pp223-231, ISSN 8756-3282.
[13] Kim CS, Choi SH, Cho KS, Chai JK, Wikesjö UM & Kim CK. (2005). Periodontal heal‐
ing in one-wall intra-bony defects in dogs following implantation of autogenous
bone or a coral-derived biomaterial. J Clin Periodontol , Vol.32, No.6, (January 2005),
pp.583-589, ISSN 0303-6979.
[14] Langer R & Vacanti JP. (1993). Tissue engineering. Science, Vol.260, No.5110, (June
1993), pp.920-926, ISSN 0036-8075.
[15] Osugi M, Katagiri W, Yoshimi R, Inukai T, Hibi H & Ueda M. (2012). Conditioned
media from mesenchymal stem cells enhancedbone regeneration in rat calvarial bone
defects. Tissue Eng Part A , Vol. 18, No. 13-14, (July 2012), pp.14779-1489, ISSN
1937-335X.
[16] Perri B, Cooper M, Lauryssen C & Anand N. (2007). Adverse swelling associated
with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J ,
Vol. 7, No.2, (May 2007), pp.235-239, ISSN 1529-9430.
[17] Toma C, Wagner WR, Bowry S, Schwartz A & Villanueva F. (2009). Fate of culture-
expanded mesenchymal stem cells in the microvasculature: in vivo observations of
cell kinetics. Circ Res , Vol.104, No.3, (February 2009), pp.398-402, ISSN 1524-4571.
[18] Vaidya R, Carp J, Sethi A, Bartol S, Craig J & Les CM. (2007). Complications of anteri‐
or cervical discectomy and fusion using recombinant human bone morphogenetic
protein-2. Eur Spine J, Vol.16, No.8, (November 2007), pp.1257-1265, ISSN 0940-6719.
[19] Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K & Nagasaka T. (2004). Autoge‐
nous injectable bone for regeneration with mesenchymal stem cells (MSCs) and pla‐
telet-rich plasma (PRP) - Tissue-engineered bone regeneration. T issue Eng, Vol.10,
No.5-6, (January 2005), pp.955-964, ISSN 1076-3279.
[20] Yamada Y, Nakamura S, Ito K, Umemura E, Hara K, Nagasaka T, Abe A, Baba S,
Furuichi Y, Izumi Y, Klein OD & Wakabayashi T. (2013). Injectable bonetissue engi‐
neeringusingexpanded mesenchymal stem cells. Stem Cells , Vol.31, No.3, pp.572-580,
ISSN 1549-4981.